M&A Deal Summary

Allergan Acquires LifeCell

On December 20, 2016, Allergan acquired medical products company LifeCell from Acelity for 2.9B USD

Acquisition Highlights
  • This is Allergan’s 8th transaction in the Medical Products sector.
  • This is Allergan’s 5th largest (disclosed) transaction.
  • This is Allergan’s 22nd transaction in the United States.
  • This is Allergan’s 4th transaction in New Jersey.

M&A Deal Summary
Date 2016-12-20
Target LifeCell
Sector Medical Products
Buyer(s) Allergan
Sellers(s) Acelity
Deal Type Divestiture
Deal Value 2.9B USD

Target

LifeCell

Branchburg, New Jersey, United States
website
LifeCell Corp. is a provider of applications in plastic and reconstructive surgeries and abdominal wall procedures.

Search 193,711 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Allergan

Parsippany, New Jersey, United States

website

Category Company
Founded 1956
Sector Life Science
Employees31,200
Revenue 15.8B USD (2018)
DESCRIPTION

Allergan is an integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company was originally established in 1956 and is based in Parsippany, New Jersey.

DEAL STATS #
Overall 32 of 38
Sector (Medical Products) 8 of 11
Type (Divestiture) 7 of 7
State (New Jersey) 4 of 4
Country (United States) 22 of 27
Year (2016) 9 of 9
Size (of disclosed) 5 of 25
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-11-22 Chase Pharmaceuticals

Washington, District of Columbia, United States

Chase Pharmaceuticals Corporation, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of improved treatments for neurodegenerative disorders. Chase's development program, if successful, will profoundly improve the symptomatic treatment of Alzheimer's disease.

Buy $125M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-02-13 ZELTIQ Aesthetics

Pleasanton, California, United States

ZELTIQ Aesthetics, Inc. is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ's first commercial product, the CoolSculpting® System, is designed to reduce unwanted fat. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues.

Buy $2.5B

Seller(S) 1

SELLER

Acelity

San Antonio, Texas, United States

website

Category Company
Founded 1976
Sector Medical Products
Employees5,700
DESCRIPTION

Acelity is a wound care and regenerative medicine company created by uniting the strengths of three companies, Kinetic Concepts, Inc., LifeCell Corporation and Systagenix Wound Management, Limited. Acelity was formed in 1976 and is based in San Antonio, Texas.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Divestiture) 1 of 1
State (New Jersey) 1 of 1
Country (United States) 1 of 1
Year (2016) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-12-01 Spiracur - SNaP Therapy System

United States

Spiracur - SNaP Therapy System is a provider of disposable negative pressure wound therapy line of products.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-06-08 Crawford Healthcare

Knutsford, United Kingdom

Crawford Healthcare Ltd. is a supplier of dermatology and woundcare products. Crawford Healthcare is based in Knutsford, United Kingdom.

Buy -
Mergr

Product

Company

Legal